Home > Clinical Trials
Check All Search

Saved trials

RECRUITING
NCT07157852
The Efficacy and Safety of Pregabalin and Mirogabalin in Patients With Fibromyalgia
674 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (NA)
Fibromyalgia


Pregabalin


Mirogabalin


Pain
COMPLETED
NCT04703322
A Study of Pexidartinib in Tenosynovial Giant Cell Tumor in Japan
9 Enrollment(s)
6 Study location(s)
INTERVENTIONAL (PHASE2)
Tenosynovial Giant Cell Tumor
NOT_YET_RECRUITING
NCT07662473
The Efficacy and Safety of Trastuzumab Deruxtecan in Advanced or Metastatic NSCLC With HER2 Over Expression
30 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE2)
NSCLC
RECRUITING
NCT04986579
Scalp Cooling in MBC
120 Enrollment(s)
2 Study location(s)
INTERVENTIONAL (PHASE2)
Metastatic Breast Cancer


Chemotherapy-induced Alopecia
RECRUITING
NCT07653893
A Phase II Observational Clinical Study on the Relationship Between Cerebrospinal Fluid Drug Concentration and Efficacy of Trastuzumab Deruxtecan in Central Nervous System Metastatic Breast Cancer
60 Enrollment(s)
1 Study location(s)
OBSERVATIONAL (None)
Central Nervous System (CNS) Metastases


Breast Cancer
RECRUITING
NCT07647016
Trastuzumab Deruxtecan Plus ivonescImab for Hormone Receptor-positive HER2 Negative Advanced Breast Cancer Study
53 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE2)
Breast Cancer
RECRUITING
NCT05950945
Trastuzumab Deruxtecan (T-DXd) in Patients Who Have Hormone Receptor-negative and Hormone Receptor-positive HER2-low or HER2 IHC 0 Metastatic Breast Cancer
250 Enrollment(s)
88 Study location(s)
INTERVENTIONAL (PHASE3)
Breast Cancer
RECRUITING
NCT04047641
Cladribine, Idarubicin, Cytarabine, and Quizartinib in Treating Patients With Newly Diagnosed, Relapsed, or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
80 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE1|||PHASE2)
Acute Myeloid Leukemia


Blasts 20 Percent or More of Bone Marrow Nucleated Cells


High Risk Myelodysplastic Syndrome


Recurrent Acute Biphenotypic Leukemia


Recurrent Acute Myeloid Leukemia


Recurrent High Risk Myelodysplastic Syndrome


Refractory Acute Myeloid Leukemia


Refractory High Risk Myelodysplastic Syndrome